Acadian Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $146K | Sell |
|
|||||
|
2024
Q4 | $226K | Buy |
|
|||||
|
2024
Q3 | $106K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $100K | Sell |
|
|||||
|
2022
Q3 | $1.16M | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $309K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.89M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3.05M | Sell |
|
|||||
|
2018
Q4 | $1.73M | Buy |
|
|||||
|
2018
Q3 | $2.57M | Buy |
|
|||||
|
2018
Q2 | $1.57M | Buy |
|
|||||
|
2018
Q1 | $498K | Buy |
|
|||||
|
2017
Q4 | $197K | Buy |
|